Edesa Biotech, Inc. (EDSA) Free cash flow 2015–2023
Edesa Biotech, Inc. (EDSA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.6MFY2023 · since FY2015: -$4.7M → -$6.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$6.6M | +46.0% |
| FY2022 | -$12.3M | +10.1% |
| FY2021 | -$13.7M | -173.9% |
| FY2020 | -$5.0M | — |
| FY2018 | -$1.3M | +74.1% |
| FY2017 | -$5.0M | -1.9% |
| FY2016 | -$4.9M | -4.7% |
| FY2015 | -$4.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice